Quantum Biopharma (QNTM) Other Working Capital Changes (2019 - 2026)
Quantum Biopharma recorded quarterly Other Working Capital Changes of -$60893.0 in Q1 2026, down 353.68% quarter-over-quarter from $24004.0 in Q4 2025, and down 142.19% year-over-year from $144345.0 in Q1 2025.
Quantum Biopharma's Other Working Capital Changes history runs 8 years deep, the most recent figure standing at -$60893.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 142.19% year-over-year to -$60893.0; the TTM figure through Mar 2026 stood at -$73283.0 (down 150.77% YoY), while the FY2025 annual figure was $15290.0, down 77.85% from the prior year.
- Other Working Capital Changes came in at -$60893.0 for Q1 2026 at Quantum Biopharma, down from $24004.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.4 million in Q2 2022 to a low of -$117683.0 in Q1 2024.
- A 5-year average of $353086.1 and a median of $192953.0 in 2023 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes soared 1475.19% in 2022 and plunged 142.19% in 2026, its largest moves.
- Quantum Biopharma's Other Working Capital Changes stood at $584306.0 in 2022, then plunged by 66.98% to $192953.0 in 2023, then slumped by 57.87% to $81289.0 in 2024, then slumped by 70.47% to $24004.0 in 2025, then tumbled by 353.68% to -$60893.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$60893.0, $24004.0, and $39294.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76,183.00 |
| Mar 31, 2026 | 76,183.00 |
| Dec 31, 2025 | 24,004.00 |
| Dec 31, 2025 | 24,004.00 |
| Sep 30, 2025 | 39,294.00 |
| Sep 30, 2025 | 39,294.00 |
| Jun 30, 2025 | 453,224.00 |
| Jun 30, 2025 | 453,224.00 |
| Mar 31, 2025 | -75,309.00 |
| Mar 31, 2025 | -75,309.00 |
| Dec 31, 2024 | 81,289.00 |
| Dec 31, 2024 | 81,289.00 |
| Sep 30, 2024 | 150,325.00 |
| Sep 30, 2024 | 150,325.00 |
| Jun 30, 2024 | 130,424.00 |
| Jun 30, 2024 | 130,424.00 |
| Mar 31, 2024 | -117,683.00 |
| Mar 31, 2024 | -117,683.00 |
| Dec 31, 2023 | 192,953.00 |
| Dec 31, 2023 | 192,953.00 |
| Sep 30, 2023 | 348,366.00 |
| Sep 30, 2023 | 348,366.00 |
| Jun 30, 2023 | 502,682.00 |
| Jun 30, 2023 | 502,682.00 |
| Mar 31, 2023 | 837,540.00 |
| Mar 31, 2023 | 837,540.00 |
| Dec 31, 2022 | 584,306.00 |
| Dec 31, 2022 | 584,306.00 |
| Sep 30, 2022 | 1.06 Mn |
| Sep 30, 2022 | 1.06 Mn |
| Jun 30, 2022 | 1.44 Mn |
| Jun 30, 2022 | 1.44 Mn |
| Mar 31, 2022 | 195,016.00 |
| Mar 31, 2022 | 195,016.00 |
| Dec 31, 2021 | -42,489.00 |
| Dec 31, 2021 | -42,489.00 |
| Sep 30, 2021 | 1.35 Mn |
| Sep 30, 2021 | 1.35 Mn |
| Jun 30, 2021 | 1.59 Mn |
| Jun 30, 2021 | 1.59 Mn |
| Mar 31, 2021 | 1.42 Mn |
| Mar 31, 2021 | 1.42 Mn |
| Dec 31, 2020 | 569,401.00 |
| Dec 31, 2020 | 569,401.00 |
| Sep 30, 2020 | 846,107.19 |
| Sep 30, 2020 | 846,107.19 |
| Jun 30, 2020 | 1.42 Mn |
| Jun 30, 2020 | 1.42 Mn |
| Mar 31, 2020 | -1.60 Mn |
| Mar 31, 2020 | -1.60 Mn |
| Dec 31, 2019 | 326,012.90 |
| Dec 31, 2019 | 326,012.90 |
| Mar 31, 2019 | 39,238.45 |
| Mar 31, 2019 | 39,238.45 |